Skip to main content
. 2023 Jan 16;9(2):e13048. doi: 10.1016/j.heliyon.2023.e13048

Table 1.

Basic clinicopathologic data for metastatic colorectal cancers.

Characteristics Category N (%)
Age Mean [years (SD)] 58.3 (9.9)
Range 30–79
Sex Male 84 (75.7)
Female 27 (24.3)
ECOG PS 0 17 (15.3)
1 53 (47.7)
2 28 (25.2)
3 13 (11.8)
Diameter of primary tumours Median [cm (IQR)] 4.0 (2.1)
Range 1.3–10.0
Diameter of paired metastases Median [cm (IQR)] 2.0 (2.0)
Range 0.6–20
Primary tumour location Right colon cancer 26 (23.4)
Left colon cancer 85 (76.6)
Histological type Adenocarcinoma 111 (100)
Histopathological grade Moderately differentiated 103 (92.8)
Poorly differentiated 8 (7.2)
Blood vessel invasion Positive 5 (4.5)
Negative 106 (95.5)
Metastatic type Synchronous metastasis 79 (71.2)
Metachronous metastasis 32 (28.8)
Metastatic site Lung 22 (19.8)
Liver 79 (71.2)
Brain 2 (1.8)
Peritoneum 8 (7.2)
K-ras gene Wild type 35 (46.1)
Mutant type 41 (53.9)
MMR/MSI status d MMR (MSI-H) 7 (6.3)
p MMR (MSI-L/MS-S) 104 (93.7)
Preoperative chemo/radiotherapy for synchronous metastasis Yes 13 (16.5)
No 66 (83.5)

Abbreviations: d MMR, deficient mismatch repair; p MMR, proficient mismatch repair; MSI-H, microsatellite instability-high; MSI-L, microsatellite instability-low; MS-S, microsatellite stability.